Company Name, Ticker, Suppliers, else..

• Gross Margin

• EBITDA Margin

• Operating Margin

• Pre-Tax Margin

• Effective Tax Rate

• Free Cash Flow Margin

• Cash Flow Margin

Valuation Comparisons

Management Effectiveness

Financial Strength

Dividend Comparisons

Thermo Fisher Scientific Inc (NYSE: TMO)

Sector • Technology Industry • Scientific & Technical Instruments

Industry • Scientific & Technical Instruments

Sector • Technology

Thermo Fisher Scientific Inc Profitability Comparisons

Select each Category to receive further Information

Select the Comparisons :

Profitability ▼

Select the Ratio:

None▼

Profitability ▼

None▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

TMO Profitability Ratio	Company	Industry	Sector	S&P 500
Gross Profit Margin (Q2 MRQ)	0 %	63.15 %	57.71 %	46.06 %
Gross Margin (Q2 TTM)	51.88 %	63.58 %	57.27 %	46.3 %
Gross Profit Margin 5 Yr. Avg.	68.72 %	61.73 %	53.08 %	47.82 %
EBITDA Margin (Q2 MRQ)	22.85 %	25.91 %	39.26 %	20.7 %
EBITDA Margin (Q2 TTM)	22.83 %	24.96 %	34.84 %	19.16 %
EBITDA Margin 5 Yr. Avg.	25.85 %	27.02 %	27.35 %	22.44 %
Operating Margin (Q2 MRQ)	17.4 %	19.85 %	28.72 %	16.03 %
Operating Margin (Q2 TTM)	17.58 %	19.35 %	27.16 %	16.33 %
Operating Margin 5 Yr. Avg.	18.95 %	19.33 %	21.24 %	17.24 %
Pre-Tax Profit Margin (Q2 MRQ)	16.04 %	19.5 %	33.68 %	13.94 %
Pre-Tax Profit Margin (Q2 TTM)	16.48 %	18.88 %	29.17 %	13.09 %
Pre-Tax Profit Margin 5 Yr. Avg.	17.5 %	18.53 %	20.85 %	12.42 %
Net Margin (Q2 MRQ)	14.52 %	17.39 %	29.04 %	11.41 %
Net Margin (Q2 TTM)	15.08 %	16.65 %	24.33 %	10.76 %
Net Margin 5 Yr. Avg.	15.79 %	16.39 %	17.64 %	9.9 %

Business Segment			Profit Margin

North America			-
Europe			-
Asia-Pacific			-
Other regions			-
Consumables			-
Instruments			-
Services			-
Total Reportable Life Sciences Solutions			-
Total Reportable Analytical Instruments			-
Total Reportable Specialty Diagnostics			-
Total Reportable Laboratory Products and Biopharma Services			-
Reconciling Items			-
Life Sciences Solutions			-
Analytical Instruments			-
Specialty Diagnostics			-
Specialty Diagnostics IntersubEliminations			-
Laboratory Products and Biopharma Services			-
Laboratory Products and Biopharma Services IntersubEliminations			-
Total Reportable Segments			-
Total Reportable Life Sciences Solutions Biosciences			-
Total Reportable Life Sciences Solutions Genetic sciences			-
Total Reportable Life Sciences Solutions BioProduction			-
Total Reportable Life Sciences Solutions Other			-
Total Reportable Analytical Instruments Chromatography and mass spectrometry			-
Total Reportable Analytical Instruments Chemical analysis			-
Total Reportable Analytical Instruments Electron microscopy			-
Total Reportable Specialty Diagnostics Clinical diagnostics			-
Total Reportable Specialty Diagnostics ImmunoDiagnostics			-
Total Reportable Specialty Diagnostics Microbiology			-
Total Reportable Specialty Diagnostics Transplant diagnostics			-
Total Reportable Specialty Diagnostics Healthcare market channel			-
Total Reportable Laboratory Products and Biopharma Services Laboratory products			-
Total Reportable Laboratory Products and Biopharma Services Research and safety market channel			-
Total Reportable Laboratory Products and Biopharma Services Pharma services			-
Total Reportable Laboratory Products and Biopharma Services Clinical research			-
Elimination of interrevenues			-
Reconciling Items Life Sciences Solutions			-
Reconciling Items Analytical Instruments			-
Reconciling Items Specialty Diagnostics			-
Reconciling Items Laboratory Products and Biopharma Services			-

Company's Cashflow Profitability & Other

Profitability Ratios	Company	Industry	Sector	S&P 500
Free Cash Flow Margin (Q2 MRQ)	13.97 %	1.23 %	6.13 %	1.39 %
Free Cash Flow Margin (Q2 TTM)	15.79 %	15.64 %	20.52 %	9.17 %
Free Cash Flow Margin 5 Yr. Avg.	-	16.76 %	21.38 %	14.29 %
Net Cash Flow Margin (Q2 MRQ)	0 %	-1.19 %	-0.15 %	0.13 %
Net Cash Flow Margin (Q2 TTM)	-2.86 %	-0.13 %	2.29 %	1.81 %
Net Cash Flow Margin 5 Yr. Avg.	-	-0.97 %	2.98 %	5.94 %
Effective Tax Rate (Q2 MRQ)	8.68 %	10.63 %	13.71 %	18.83 %
Effective Tax Rate (Q2 TTM)	7.82 %	10.85 %	17.36 %	19.33 %
Effective Tax Rate 5 Yr. Avg.	8.57 %	10.78 %	16.34 %	19.82 %

Note
To view Detail Information & Trends click on Individual Category. Example: Y / Y Revenue Change (MRQ) or To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table. Example: Industry Sector S&P 500 For explanation of terms visit: Glossary

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.